ライフサイエンスコーパス: endothelial marker

1 We previously identified CLEC14A as a tumour endothelial marker.

2 5+ and are thought to lose the expression of endothelial markers.

3 sing human specific hepatocyte, biliary, and endothelial markers.

4 lial dysfunction, as assessed by circulating endothelial markers.

5 of all dividing cells are immunoreactive for endothelial markers.

6 ting in formation of blood and activation of endothelial markers.

7 and retained expression of general vascular endothelial markers.

8 and graft outcomes to a greater extent than endothelial markers.

9 zed by immunoreactivity for cytokeratins and endothelial markers.

10 fferentiation and sustains the expression of endothelial markers.

11 ALK2, chondrocytes and osteoblasts expressed endothelial markers.

12 SECs have both hematopoietic and endothelial markers.

13 scular endothelial growth factor (VEGF), and endothelial markers.

14 in a two-step screen to predict novel tumour endothelial markers.

15 e subtraction was employed to predict tumour endothelial markers.

16 nesium intake is related to inflammatory and endothelial markers.

17 tric analysis and quantifying mRNA levels of endothelial markers.

18 and showed varying immunoreactivity for all endothelial markers.

19 er have focal regions that lack these common endothelial markers.

20 technology is useful for in vivo imaging of endothelial markers.

21 ally new pan-endothelial and tissue-specific endothelial markers.

22 Tumor endothelial marker 1 (TEM1/endosialin) is a tumor vascul

23 Tumor endothelial marker 1 (TEM1; also known as endosialin or

24 Tumor endothelial marker 1 (Tem1; endosialin) is the prototypi

25 Human tumor endothelial marker 1/endosialin (TEM1/endosialin) was re

26 CD248 (tumor endothelial marker 1/endosialin) is found on stromal cel

27 (alternatively known as endosialin or tumour endothelial marker-1) is also a member of this family an

28 rated by immunostaining for with a lymphatic endothelial marker 10.1.1.

29 One binding partner was identified as tumor endothelial marker-4 (TEM4; ARHGEF17), a guanine nucleot

30 protein-coupled receptor (GPCR) GPR124/tumor endothelial marker 5 is highly expressed in central nerv

31 protein-coupled receptor 124 (GPR124) (tumor endothelial marker 5, TEM5), an orphan member of the adh

32 Tumor endothelial marker 7 (TEM7) was recently identified as a

33 in 2 (CMG2) and anthrax toxin receptor/tumor endothelial marker 8 (ATR/TEM8).

34 eceptors, anthrax toxin receptor (ATR)/tumor endothelial marker 8 (TEM8) and capillary morphogenesis

35 wo identified anthrax toxin receptors: tumor endothelial marker 8 (TEM8) and capillary morphogenesis

36 toxin receptors (ATRs), encoded by the tumor endothelial marker 8 (TEM8) gene.

37 Tumor endothelial marker 8 (TEM8) is a recently described prot

38 Tumor endothelial marker 8 (TEM8) is induced in tumor-associat

39 Anthrax toxin receptor 1 (ANTXR1)/tumor endothelial marker 8 (TEM8) is one of two known proteina

40 ins, protective antigen (PA), binds to tumor endothelial marker 8 (TEM8) or capillary morphogenesis p

41 sured in cells specifically expressing tumor endothelial marker 8 (TEM8) or capillary morphogenesis p

42 he more important for pathogenesis and tumor endothelial marker 8 (TEM8) playing a minor role.

43 Tumor endothelial marker 8 (TEM8) was initially identified as

44 Tumor endothelial marker 8 (TEM8), also known as anthrax toxin

45 Surface expression of toxin receptors tumor endothelial marker 8 and capillary morphogenesis gene 2,

46 ular receptors: anthrax toxin receptor/tumor endothelial marker 8 and capillary morphogenesis protein

47 The soluble anthrax toxin receptor/tumor endothelial marker 8 and capillary morphogenesis protein

48 The anthrax toxin receptor/tumor endothelial marker 8 and CMG2 VWA domains share approxim

49 llary morphogenesis gene 2 protein and tumor endothelial marker 8 with high affinity.

50 capillary morphogenesis gene 2 (CMG2), tumor endothelial marker 8, and beta1-integrin, and, with the

51 1 integrin, the integrin-like receptor tumor endothelial marker-8 (TEM8), VEGFR2 and NFAT.

52 We therefore measured a panel of plasma endothelial markers acutely and in convalescence in Mala

53 e differentiated cells co-expressed CD31, an endothelial marker, along with alpha-SMA, as seen by dou

54 Glut1 is an endothelial marker and is the principal glucose transpor

55 ascular endothelial cells lost expression of endothelial markers and acquired expression of mesenchym

56 "Transitional" cells, coexpressing both endothelial markers and alpha-SM-actin, were consistentl

57 Similarly, this co-expression of endothelial markers and alpha-SMA was detected in a subp

58 e change in the EYFP population with loss of endothelial markers and an increase in mononuclear marke

59 of circulation express the highest levels of endothelial markers and do not generate blood cells in v

60 -1 and podoplanin used as specific lymphatic endothelial markers and Ki-67 as a proliferation marker.

61 tures that were positive for three lymphatic endothelial markers and negative for three blood vessel

62 ead showed the stable expression of multiple endothelial markers and the capacity to form capillary n

63 the absence of RUNX1, the down-regulation of endothelial markers and the formation of round cells, a

64 identification of tissue-specific lymphatic endothelial markers and the study of congenital lymphede

65 Combining these 2 functional endothelial markers and using confocal microscopy to obt

66 s based on the expression of VE-cadherin and endothelial markers and with lack of CD45 and hematopoie

67 neuronal marker; vWF, VEGFA, VEGFC and IL-8, endothelial markers; and PPARgamma and FABP4, adipose ma

68 n of transductional targeting to a pulmonary endothelial marker (angiotensin-converting enzyme, ACE)

69 YFP reporter quail embryos combined with the endothelial marker antibody QH1 provides definitive evid

70 These cells express endothelial markers, are heterogeneous for early hematop

71 ated into ECs (miPSC-ECs), the expression of endothelial markers, arterial endothelial markers, pro-a

72 nments recruit progenitor cells that express endothelial markers, as determined by staining with isol

73 f cDNA libraries and predict putative tumour endothelial markers before entering the laboratory.

74 The clones expressed endothelial markers but showed potential to further diff

75 Acquisition of endothelial markers by activated T cells occurred as par

76 phatics display a typical panel of lymphatic endothelial markers by immunohistochemistry.

77 bed the heart vasculature for heart-specific endothelial markers by phage display.

78 ely 30 to 50% of fibroblasts coexpressed the endothelial marker CD31 and markers of fibroblasts and m

79 report, the co-expression of HLA-DR and the endothelial marker CD31 are used to identify RMEC as a d

80 lonal lines showed reduced staining with the endothelial marker CD31 in Matrigel plug assay, indicati

81 1 was specifically colocalized with vascular endothelial marker CD31 surrounded by type IV collagen.

82 tained with Cy-annexin V and antibody to the endothelial marker CD31).

83 C1 expression closely paralleled that of the endothelial marker CD31, and the peak level of STC1 expr

84 stem cell marker SCA-1, also co-express the endothelial marker CD31, suggesting the presence of endo

85 in level of staining for TGF-betaRII or the endothelial marker CD31.

86 ith the podocyte marker WT1 but not with the endothelial marker CD31.

87 lpha(1), alpha(2), beta(3), and beta(5); the endothelial marker CD31; and metalloproteinases MMP-2 an

88 wth and immunohistochemical staining for the endothelial markers CD31 and VEGFR-2 and terminal deoxyn

89 on-induced angiogenesis and a panel of known endothelial markers (CD31, VE-cadherin, BS-I lectin), we

90 negative for: hematopoietic (CD34, CD45) and endothelial markers (CD31, vWf, von Willebrand factor).

91 ith colocalization studies with TUNEL and an endothelial marker, CD31, in tumor sections of Ad-MMP-2-

92 hemically characterized by the expression of endothelial markers, CD31, and P1H12.

93 ained prostatectomy tumor block sections for endothelial marker CD34 and assessed microvessel density

94 d the expression of HIF1alpha, VEGF, and the endothelial marker CD34 in a mouse xenograft model of br

95 significant correlation between SUV(max) and endothelial markers (CD34 and CD105).

96 l growth factor receptor 3) as well as blood endothelial markers (CD34, endomucin, platelet endotheli

97 Endothelial markers colocalize with multipotent and oste

98 hogenesis of PPH; the normalization of these endothelial markers concomitant with improvement in hemo

99 or inhibitor-1, protein C, antithrombin, and endothelial markers (E-selectin, intracellular adhesion

100 induced endothelium dysfunction, we measured endothelial markers, endothelium-dependent vasodilation,

101 injury models may induce lineage-independent endothelial marker expression in mesenchymal cells.

102 The SMC-converted ECs exhibit typical endothelial markers expression and endothelial functions

103 However, the expression of an early endothelial marker fli1a and vascular morphogenesis appe

104 uently differentiate into cells that express endothelial markers, function in vitro as mature endothe

105 d consistent up-regulation of certain glioma endothelial marker genes across patient samples.

106 ith antiserum to human ecNOS, the functional endothelial marker GLUT1, and the anatomical endothelial

107 Inclusion of the endothelial markers ICAM1 and thrombomodulin in a logist

108 lly using podoplanin as a specific lymphatic endothelial marker in 21 globes that had been enucleated

109 27 genes were predicted tumour endothelial markers in multiple tissues based on the sec

110 th muscle actin, but negative for desmin and endothelial markers including Factor VIII, clonal design

111 , designated IEM, which expresses a range of endothelial markers, including Von Willibrand Factor VII

112 We have shown that podoplanin, a lymphatic endothelial marker, is highly expressed in oral cancer a

113 double immunostains for the novel lymphatic endothelial marker LYVE-1 and for the panvascular marker

114 munohistochemical staining for the lymphatic endothelial marker LYVE-1 was done to determine the cont

115 sed expression pattern and co-localised with endothelial markers on sinusoidal endothelium.

116 , more than 86% of these cells expressed the endothelial markers P1H12, CD34, and CD31 and leukocyte

117 smooth muscle (SM) alpha-actin; whereas the endothelial marker, PECAM-1, was lost from the invaded c

118 bryos based on the lack of expression of the endothelial marker platelet endothelial cell adhesion mo

119 nto immunoliposomes (Ab-MJ33/IL) targeted to endothelial marker platelet endothelial cell adhesion mo

120 a cobblestone cell morphology, expression of endothelial markers (platelet endothelial cell-adhesion

121 EM and immunohistochemical staining with the endothelial marker, platelet and endothelial cell adhesi

122 Immunostaining of an endothelial marker, platelet endothelial cell adhesion m

123 receptor (LYVE-1, a routinely used lymphatic endothelial marker), podoplanin, Flt4/VEGFR3, Sca-1, CD1

124 g/ml each), explants formed QH-1 (anti-quail endothelial marker)-positive mesenchymal cells, which in

125 -Bromo-2'-deoxyuridine incorporation and neo-endothelial markers present in the microvasculature of M

126 expression of endothelial markers, arterial endothelial markers, pro-angiogenic cytokines, and Notch

127 schaemic leukoaraiosis group had a different endothelial marker profile, with lower levels of TFPI (P

128 These tumor endothelial marker proteins also exhibited increased exp

129 Based on the expression of an quail endothelial marker, QH-1, the initial emergence of endot

130 and Ephrin receptor B4, arterial and venous endothelial markers, respectively.

131 d to tissues undergoing inflammation, and an endothelial marker responsible for tumour homing to the

132 entified by expression of lacZ and Flt-1, an endothelial marker shown to be absent on SP cells.

133 rived CD11b+ macrophages expressed lymphatic endothelial markers such as LYVE-1 and Prox-1 under infl

134 pulations uniformly co-expressed myeloid and endothelial markers, suggesting that peripheral blood pr

135 totrophoblasts fail to express most of these endothelial markers, suggesting that this adhesion pheno

136 pha1, Ialpha2, and IIIalpha1 are known tumor endothelial markers, suggesting that TSP1 coordinately r

137 Tumor endothelial marker (TEM)8 was uncovered as a gene expres

138 Tumor endothelial markers (TEM) are antigens enriched in tumor

139 Tumor endothelial markers (TEMs) that are highly expressed in

140 We recently identified genes encoding tumor endothelial markers (TEMs) that displayed elevated expre

141 d through the recent identification of tumor endothelial markers (TEMs).

142 Aggressive melanoma cells may express endothelial markers that can be used to calculate microv

143 As CD34(+) cells acquired mature endothelial markers, they exhibit robust oscillations of

144 d xenografts (PDXs) were found to co-express endothelial marker Tie-2.

145 Based on protein expression levels of common endothelial markers using flow cytometry, 3 subpopulatio

146 Cells expressing the lymphatic endothelial marker vascular endothelial growth factor re

147 r percentage of cells expressed the specific endothelial marker VE-cadherin (5.2+/-0.7%) or stem/prog

148 growth, but some leukocytes up-regulated the endothelial marker VE-cadherin.

149 f mesenchymal markers and down-regulation of endothelial markers via transforming growth factor/Smad

150 endothelial marker GLUT1, and the anatomical endothelial marker von Willebrand factor.

151 , left ventricular protein expression of the endothelial markers von Willebrand factor and neuregulin

152 reproducible, and show characteristic brain endothelial markers (von Willebrand factor, glucose tran

153 ; in both places, it is co-localized with an endothelial marker, von Willebrand factor, and laminin-1

154 xpression occurred together with that of the endothelial marker, von Willebrand factor, in human and

155 Immunostaining of the endothelial marker vWf revealed a parallel upregulation

156 The greatest immunoreactivity for endothelial markers was observed with CD34 and vWF and l

157 A new leukocyte population expressing DC and endothelial markers was uncovered in mouse and human ova

158 To identify tumor-specific endothelial markers, we performed a microarray on tumor-

159 that localized to the lumen and stained for endothelial markers were also identified.

160 cells coexpressing cytokeratins and the two endothelial markers were clearly identifiable.

161 Most of these tumor endothelial markers were expressed in a wide range of tu

162 Endothelial markers were positive only in the single lay

163 pha, or IL-1beta decreased the expression of endothelial markers, whereas mesenchymal markers increas

164 the first step towards identifying selective endothelial markers, which may be useful in targeting ce

165 e G-protein-coupled receptor RDC1 as a tumor endothelial marker whose expression is distinctly induce

166 actin (a marker of arterioles) and CD34 (an endothelial marker), with separate analyses on grey and